Q3 2023 Results - Reimagining Medicine slide image

Q3 2023 Results - Reimagining Medicine

Company overview Financial review Conclusions Appendix References Vas Narasimhan, M.D. Chief Executive Officer 28 Investor Relations | Q3 2023 Results NOVARTIS | Reimagining Medicine
View entire presentation